ADVERTISEMENT

International

Cloudy Tariff Conditions Expected To Linger In US

White House announces president extends deadline he set in April for other countries to make new tariff deals from July 9 to Aug. 1, when the administration will start sending letters warning other countries that higher tariffs could take effect.

Kennedy Appears Ill-Informed On Major Pharma Priorities, Creating Unique Lobbying Dynamics

Health and Human Services secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.

US FDA’s Tough Talk On Talc: Regulating In An Echo Chamber

An FDA “expert roundtable” on talc produced a new talking point on a potential drug safety risk, but the basis of that claim is difficult to determine.

US Tariff Overhang Weighs on Chinese API Exports

Chinese API exports to US fell 24% year-on-year to $255m in May, when US and China called a truce in a previously escalating trade war.

US Consumer Health People News: Thrive, Cypress Minerals, Curaleaf, Lemon Fresh, Nature Made

Curaleaf appoints president, marketing, digital, and brand leads; Lemon Perfect adds marketing, strategy chiefs; Nature Made, HelloFresh stir up ‘Gut Friendly’ recipes; and Thrive serves promotions for USA Pickleball.

Biotech Investor, One-Time US FDA Commissioner Candidate Returns To HHS As RFK Jr.’s Top Deputy

Jim O’Neill recently was CEO of age-related diseases group SENS Research Foundation. After serving in HHS from 2002 to 2008, he became a managing director of Clarium Capital global investment fund and was Thiel Foundation CEO, funding nonprofits that promote technology.

Perrigo Combines Americas, International Leads Into Global Post In Latest Move To Boost Results

Roberto Khoury, Perrigo’s international lead for a year, moves to CCO while his counterpart for the Americas region appointed in September 2023, Catherine "Triona" Schmelter, is leaving with her post eliminated in the firm’s changes.

What’s Next? Five Things To Look Out For In July

Generics Bulletin previews the most noteworthy and anticipated events for July 2025.

US FDA Has Lists To Assure Progress On Supplement Sector Regulations, NDIN Guidance

The agency says items on its Human Foods Program’s proposed agenda for guidance “to complete during 2025” include identity and safety information for NDI notifications. Its announcement also links to document about a separate key industry question, a rulemaking which would recognize NAC as a lawful

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

Utah Delegation’s Support For Supplement Industry Key For Caucus Restart In Congress

Dietary Supplement Caucus e-launched the 119th Congress with Utah Republican House member Mike Kennedy and Texas Democrat member Marc Veasey as co-chairs and with a total of nine senators and 20 House members spanning both parties.

US Adverse Event Report Forms Replace ‘Gender’ Options With Male Or Female ‘Sex’ Question

Modifications to forms FDA 3500, for voluntary reporting by healthcare professionals, and 3500A, for mandatory reporting by manufacturers, marketers or facilities, include limiting changing gender question to sex and asking for only male or female answer.